Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nuclear Receptor Coactivator 3 | 5 | 2021 | 346 | 1.350 |
Why?
|
| Virus Latency | 4 | 2021 | 61 | 1.020 |
Why?
|
| HIV-1 | 5 | 2021 | 464 | 0.860 |
Why?
|
| Cell Proliferation | 4 | 2021 | 2315 | 0.780 |
Why?
|
| Histone Code | 2 | 2017 | 52 | 0.690 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 216 | 0.640 |
Why?
|
| Histones | 2 | 2017 | 528 | 0.550 |
Why?
|
| E2F1 Transcription Factor | 1 | 2016 | 47 | 0.510 |
Why?
|
| Phosphorylation | 3 | 2018 | 1615 | 0.440 |
Why?
|
| Receptor, ErbB-2 | 1 | 2016 | 497 | 0.410 |
Why?
|
| DNA | 1 | 2016 | 1608 | 0.350 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2017 | 135 | 0.310 |
Why?
|
| Transcriptional Activation | 2 | 2018 | 483 | 0.240 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2021 | 6 | 0.190 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 1889 | 0.180 |
Why?
|
| HIV Infections | 3 | 2021 | 1858 | 0.160 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2021 | 473 | 0.160 |
Why?
|
| Ubiquitin-Specific Proteases | 1 | 2018 | 20 | 0.150 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 304 | 0.150 |
Why?
|
| Phosphofructokinase-2 | 1 | 2018 | 24 | 0.150 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2017 | 41 | 0.150 |
Why?
|
| Virus Integration | 1 | 2017 | 44 | 0.140 |
Why?
|
| Virus Activation | 1 | 2017 | 86 | 0.140 |
Why?
|
| Leukemia Virus, Murine | 2 | 2006 | 4 | 0.140 |
Why?
|
| Lysosomes | 1 | 2018 | 232 | 0.130 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2016 | 90 | 0.130 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 3301 | 0.120 |
Why?
|
| Binding Sites | 2 | 2016 | 1298 | 0.120 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 2480 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 413 | 0.110 |
Why?
|
| DNA Replication | 1 | 2016 | 345 | 0.110 |
Why?
|
| Chromatin | 1 | 2017 | 551 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 713 | 0.110 |
Why?
|
| Glucose | 1 | 2018 | 876 | 0.110 |
Why?
|
| Transcription, Genetic | 2 | 2017 | 1704 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2016 | 619 | 0.110 |
Why?
|
| Mice, Knockout | 1 | 2021 | 3780 | 0.110 |
Why?
|
| Carnitine Acyltransferases | 1 | 2012 | 6 | 0.100 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 717 | 0.100 |
Why?
|
| Muscular Diseases | 1 | 2012 | 103 | 0.090 |
Why?
|
| Mice | 4 | 2021 | 17637 | 0.080 |
Why?
|
| Humans | 12 | 2021 | 122409 | 0.080 |
Why?
|
| Cell Separation | 2 | 2006 | 237 | 0.080 |
Why?
|
| Immunodeficiency Virus, Feline | 1 | 2006 | 4 | 0.070 |
Why?
|
| Retroviridae Infections | 1 | 2006 | 10 | 0.070 |
Why?
|
| Animals | 6 | 2021 | 33891 | 0.070 |
Why?
|
| Ribonucleases | 1 | 2006 | 55 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1677 | 0.070 |
Why?
|
| Lentivirus | 1 | 2006 | 84 | 0.070 |
Why?
|
| Genetic Vectors | 2 | 2006 | 973 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2016 | 4514 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2021 | 3076 | 0.050 |
Why?
|
| Cell Line | 3 | 2017 | 2787 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2021 | 76 | 0.050 |
Why?
|
| Drug Discovery | 1 | 2021 | 174 | 0.040 |
Why?
|
| Cycloheximide | 1 | 2018 | 43 | 0.040 |
Why?
|
| Phosphoserine | 1 | 2018 | 41 | 0.040 |
Why?
|
| Transketolase | 1 | 2018 | 19 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 36 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 44 | 0.040 |
Why?
|
| Chemokine CCL19 | 1 | 2017 | 6 | 0.040 |
Why?
|
| Ionomycin | 1 | 2017 | 15 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2017 | 70 | 0.040 |
Why?
|
| Benzylidene Compounds | 1 | 2017 | 5 | 0.040 |
Why?
|
| Piperidones | 1 | 2017 | 7 | 0.040 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2017 | 19 | 0.040 |
Why?
|
| Purines | 1 | 2018 | 107 | 0.040 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2017 | 14 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2018 | 222 | 0.040 |
Why?
|
| Glycolysis | 1 | 2018 | 145 | 0.040 |
Why?
|
| Protein Interaction Maps | 1 | 2017 | 77 | 0.040 |
Why?
|
| Acetylation | 1 | 2017 | 166 | 0.040 |
Why?
|
| Methylation | 1 | 2017 | 227 | 0.040 |
Why?
|
| Plasmids | 1 | 2018 | 516 | 0.030 |
Why?
|
| Receptors, Steroid | 1 | 2018 | 269 | 0.030 |
Why?
|
| RNA Interference | 1 | 2018 | 497 | 0.030 |
Why?
|
| Female | 3 | 2018 | 64937 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 655 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 746 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2012 | 2442 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 874 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 581 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 788 | 0.030 |
Why?
|
| Virus Replication | 1 | 2017 | 603 | 0.030 |
Why?
|
| Proteomics | 1 | 2017 | 478 | 0.030 |
Why?
|
| Mutation | 3 | 2018 | 5786 | 0.030 |
Why?
|
| Ketosis | 1 | 2012 | 15 | 0.030 |
Why?
|
| Hyperammonemia | 1 | 2012 | 60 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 445 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1674 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2012 | 191 | 0.020 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2010 | 66 | 0.020 |
Why?
|
| Systems Biology | 1 | 2010 | 61 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 123 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2012 | 338 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 317 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 353 | 0.020 |
Why?
|
| Mammals | 1 | 2010 | 263 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 390 | 0.020 |
Why?
|
| Adiposity | 1 | 2010 | 179 | 0.020 |
Why?
|
| Phenotype | 2 | 2010 | 4217 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 4492 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 340 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 355 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 1622 | 0.020 |
Why?
|
| Body Composition | 1 | 2010 | 472 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2017 | 2590 | 0.020 |
Why?
|
| Leupeptins | 1 | 2006 | 26 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 1403 | 0.020 |
Why?
|
| Body Weight | 1 | 2010 | 933 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2006 | 104 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2006 | 90 | 0.020 |
Why?
|
| Cricetinae | 1 | 2006 | 411 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 927 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 658 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2006 | 900 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2010 | 629 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2006 | 622 | 0.020 |
Why?
|
| Male | 4 | 2012 | 59575 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 2541 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 2698 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 3887 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 4383 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2006 | 876 | 0.010 |
Why?
|